{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:38:35Z","timestamp":1773722315405,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PAINCAGE FP7 Collaborative","award":["603191"],"award-info":[{"award-number":["603191"]}]},{"name":"Italian Foundation for Multiple Sclerosis"},{"name":"Xiamen Bioway Biotech Group Co., Ltd"},{"name":"PRIN","award":["2008R23Z7K"],"award-info":[{"award-number":["2008R23Z7K"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.01.035","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T05:01:43Z","timestamp":1486098103000},"page":"134-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nerve growth factor derivative NGF61\/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization"],"prefix":"10.1016","volume":"117","author":[{"given":"C.","family":"Severini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Petrocchi Passeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Ciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Florenzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"D'Onofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Arisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Possenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Calissano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.035_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(95)00024-M","article-title":"Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones","volume":"63","author":"Andreev","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(99)02784-1","article-title":"Effect of topical application of nerve-growth factor on pressure ulcers","volume":"354","author":"Bernabei","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1113\/jphysiol.2003.039990","article-title":"Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor","volume":"551","author":"Bonnington","year":"2003","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neulet.2006.05.020","article-title":"Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons","volume":"403","author":"Bowles","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1172\/JCI42143","article-title":"Some new insights into the molecular mechanisms of pain perception","volume":"120","author":"Brown","year":"2010","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib8","doi-asserted-by":"crossref","first-page":"e17321","DOI":"10.1371\/journal.pone.0017321","article-title":"Taking pain out of NGF: a \u201cpainless\u201d NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity","volume":"6","author":"Capsoni","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib9","doi-asserted-by":"crossref","first-page":"e37555","DOI":"10.1371\/journal.pone.0037555","article-title":"Intranasal \u201cpainless\u201d human Nerve Growth Factor slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice","volume":"7","author":"Capsoni","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib10","article-title":"The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human Nerve Growth Factor","author":"Capsoni","year":"2016","journal-title":"Brain (Accepted)"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JAD-2008-15210","article-title":"Towards non invasive nerve growth factor therapies for Alzheimer's disease","volume":"15","author":"Cattaneo","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/CS20050163","article-title":"Neurotrophin signalling in health and disease","volume":"110","author":"Chao","year":"2006","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/exnr.1997.6608","article-title":"Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat","volume":"147","author":"Christensen","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2009.11.146","article-title":"In\u00a0vitro receptor binding properties of a \u201cpainless\u201d NGF mutein, linked to hereditary sensory autonomic neuropathy type V","volume":"391","author":"Covaceuszach","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5381.1994.tb16174.x","article-title":"The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat","volume":"113","author":"Davis","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib18","first-page":"3","article-title":"Trafficking the NGF signal: implications for normal and degenerating neurons","volume":"146","author":"Delcroix","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib19","first-page":"150","article-title":"Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor","volume":"46","author":"Donnerer","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-2236(93)90133-7","article-title":"Bradykinin and inflammatory pain","volume":"16","author":"Dray","year":"1993","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-6147(89)90166-1","article-title":"Effects of nerve growth factor on cholinergic brain neurons","volume":"10","author":"Dreyfus","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease","volume":"9","author":"Eriksdotter-Jonhagen","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000336051","article-title":"Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease","volume":"33","author":"Eriksdotter-Jonhagen","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-016-0195-9","article-title":"Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device","volume":"8","author":"Eyjolfsdottir","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(93)90268-D","article-title":"Sensory neuropeptide release by bradykinin: mechanisms and pathophysiological implications","volume":"47","author":"Geppetti","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2007-12105","article-title":"One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?","volume":"12","author":"Giacobini","year":"2007","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157015906778019554","article-title":"Inflammatory pain: the cellular basis of heat hyperalgesia","volume":"4","author":"Huang","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nbdi.2000.0360","article-title":"Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain","volume":"8","author":"Ji","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fncel.2015.00229","article-title":"Functional expression of bradykinin B1 and B2 receptors in neonatal rat trigeminal ganglion neurons","volume":"9","author":"Kawaguchi","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical treatment with nerve growth factor for corneal neurotrophic ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib31","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-139-8-200310210-00006","article-title":"Topical treatment of pressure ulcers with nerve growth factor: a randomized clinical trial","volume":"139","author":"Landi","year":"2003","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1096-9861(19960212)365:3<355::AID-CNE2>3.0.CO;2-3","article-title":"Electrophysiological properties of neurones with CGRP-like immunoreactivity in rat dorsal root ganglia","volume":"365","author":"Lawson","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/mcne.2001.1073","article-title":"Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons","volume":"19","author":"Lee","year":"2002","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib35","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1523\/JNEUROSCI.13-05-02136.1993","article-title":"Nerve growth factor-induced hyperalgesia in the neonatal and adult rat","volume":"13","author":"Lewin","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1254\/jphs.11160FP","article-title":"Dragon's blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats","volume":"118","author":"Li","year":"2012","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/337362a0","article-title":"Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons","volume":"337","author":"Lindsay","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(94)E0017-B","article-title":"Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves","volume":"45","author":"Maggi","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1460-9568.1997.tb01462.x","article-title":"Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord","volume":"9","author":"Malcangio","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib41","doi-asserted-by":"crossref","first-page":"e0136425","DOI":"10.1371\/journal.pone.0136425","article-title":"Functional characterization of human ProNGF and NGF mutants: identification of NGF P61SR100E as a \u201cpainless\u201d lead investigational candidate for therapeutic applications","volume":"10","author":"Malerba","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3233\/JAD-2008-13109","article-title":"Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells","volume":"13","author":"Matrone","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/PL00000920","article-title":"Neurotrophins and neuronal differentiation in the central nervous system","volume":"58","author":"McAllister","year":"2001","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00221-009-1814-5","article-title":"Excitation and sensitization of nociceptors by bradykinin: what do we know?","volume":"196","author":"Mizumura","year":"2009","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib45","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib46","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1523\/JNEUROSCI.15-11-07633.1995","article-title":"Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons","volume":"15","author":"Noguchi","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0306-4522(97)00465-X","article-title":"Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury","volume":"83","author":"Petersen","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib48","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1152\/physrev.00048.2010","article-title":"Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors","volume":"92","author":"Petho","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.410360221","article-title":"The effect of systemically administered recombinant human nerve growth factor in healthy human subjects","volume":"36","author":"Petty","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3959(00)00393-6","article-title":"Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat","volume":"90","author":"Pezet","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","article-title":"Neurotrophins: mediators and modulators of pain","volume":"29","author":"Pezet","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/jpet.103.060335","article-title":"Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice","volume":"308","author":"Rashid","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib53","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.102.032797","article-title":"Cellular mechanisms of neurogenic inflammation","volume":"302","author":"Richardson","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib54","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1476-5381.1995.tb15035.x","article-title":"Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia","volume":"115","author":"Safieh-Garabedian","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0028-3908(97)00065-8","article-title":"Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice","volume":"36","author":"Seabrook","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib57","doi-asserted-by":"crossref","first-page":"15301","DOI":"10.1038\/srep15301","article-title":"Bv8\/prokineticin 2 is involved in Abeta-induced neurotoxicity","volume":"5","author":"Severini","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.expneurol.2005.10.006","article-title":"Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors","volume":"197","author":"Skoff","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib59","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1046\/j.1460-9568.2000.00218.x","article-title":"Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A","volume":"12","author":"Smith","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib60","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2013","article-title":"Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease","volume":"94","author":"Steinhoff","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1152\/jn.2002.88.1.544","article-title":"Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1","volume":"88","author":"Sugiura","year":"2002","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1152\/jn.00086.2004","article-title":"Role of calcitonin gene-related peptide in the sensitization of dorsal horn neurons to mechanical stimulation after intradermal injection of capsaicin","volume":"92","author":"Sun","year":"2004","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2230.2009.03636.x","article-title":"Neurotropin inhibits both capsaicin-induced substance P release and nerve growth factor-induced neurite outgrowth in cultured rat dorsal root ganglion neurones","volume":"35","author":"Taneda","year":"2010","journal-title":"Clin. Exp. Dermatol"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2004.07.076","article-title":"Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons","volume":"498","author":"Tang","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib66","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1471-4159.2006.03830.x","article-title":"Substance P release evoked by capsaicin or potassium from rat cultured dorsal root ganglion neurons is conversely modulated with bradykinin","volume":"97","author":"Tang","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0304-3959(94)00271-F","article-title":"Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat","volume":"62","author":"Thompson","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A\u00a0phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib69","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","article-title":"Nerve growth factor gene therapy: activation of neuronal responses in alzheimer disease","volume":"72","author":"Tuszynski","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib70","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1073\/pnas.0611253104","article-title":"The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain","volume":"104","author":"Ugolini","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib71","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1523\/JNEUROSCI.14-08-04987.1994","article-title":"Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture","volume":"14","author":"Vasko","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF01187079","article-title":"Histochemical characterization of sensory neurons with high-affinity receptors for nerve growth factor","volume":"18","author":"Verge","year":"1989","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib73","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1523\/JNEUROSCI.15-03-02081.1995","article-title":"Differential influence of nerve growth factor on neuropeptide expression in\u00a0vivo: a novel role in peptide suppression in adult sensory neurons","volume":"15","author":"Verge","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib74","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.1523\/JNEUROSCI.1536-14.2014","article-title":"Nerve growth factor sensitizes adult sympathetic neurons to the proinflammatory peptide bradykinin","volume":"34","author":"Vivas","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib75","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1523\/JNEUROSCI.2393-05.2005","article-title":"Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission","volume":"25","author":"Wang","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-4522(94)90366-2","article-title":"Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity","volume":"62","author":"Woolf","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0896-6273(00)80487-0","article-title":"Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology","volume":"20","author":"Woolf","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.01.035_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12264-007-0032-z","article-title":"Regulatory effect of nerve growth factor on release of substance P in cultured dorsal root ganglion neurons of rat","volume":"23","author":"Yang","year":"2007","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2017.01.035_bib79","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1152\/jn.00356.2004","article-title":"A\u00a0developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGF","volume":"92","author":"Zhu","year":"2004","journal-title":"J.\u00a0Neurophysiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:11:01Z","timestamp":1587409861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":79,"alternative-id":["S0028390817300345"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.035","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nerve growth factor derivative NGF61\/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}